Designed for

Eye Care Professionals

Support your treatments with advanced

neuromodulation and iontophoresis

Indications for the use of the

MagnoVision™ MG10 Device

Advanced retinal imaging for precise diagnosis and better patient outcomes.

Designed for

Eye Care Professionals

Support your treatments with advanced

neuromodulation and iontophoresis

Indications for the use of the

MagnoVision™ MG10 Device

Advanced retinal imaging for precise diagnosis and better patient outcomes.

Designed for

Eye Care Professionals

Support your treatments with advanced

neuromodulation and iontophoresis

Indications for the use of the

MagnoVision™ MG10 Device

Advenced retinal imaging for precise diagnosis and better patient outcomes.

Indications for the use of the

MagnoVision™ MG10 Device

Advenced retinal imaging for precise diagnosis and better patient outcomes.

Retinal Ischemic

Diseases

Retinal Ischemic Diseases

3 sessions in 2 months

Optic Toxic

Neuropathies

Optic ToxicNeuropathies

10 sessions of MAGNOVISION

Retinitis

Pigmentosa

Retinis Pigmentosa

One session per week

Chronic Central Serous

Chorioretinopathy

Chronic Central Serous

Chorioretinopathy

Chronic Central Cerous Chorioretinopathy

3 sessions in 2 months

Optic Toxic

Neuropathies

Optic ToxicNeuropathies

10 sessions of MAGNOVISION

Retinal Ischemic

Diseases

Retinal Ischemic Diseases

3 sessions in 2 months

Optic Toxic

Neuropathies

Optic ToxicNeuropathies

10 sessions of MAGNOVISION

Retinitis

Pigmentosa

Retinis Pigmentosa

One session per week

Chronic Central Serous

Chorioretinopathy

Chronic Central Cerous Chorioretinopathy

3 sessions in 2 months

Optic Toxic

Neuropathies

Optic ToxicNeuropathies

10 sessions of MAGNOVISION

How MagnoVision™ Works

neuromodulation
iontophoresis

Neuromodulation effect:

Iontophoresis effect:

1

2

2000 mGauss electromagnetic field, 42 hertz frequency

for 30 minutes from 9 different coils repetitively stimulates

the retina, optic nerve and visual pathways. Neuronal ion

channels are externally stimulated and photoreceptors and

ganglion cells in the retina are reactivated. Photoreceptors

in dormant sleep mode are reactivated. Nerve fibers switch

from Off mode to On mode.

2000 mGauss electromagnetic field, 42 hertz frequency

for 30 minutes from 9 different coils repetitively stimulates

the retina, optic nerve and visual pathways. Neuronal ion

channels are externally stimulated and photoreceptors and

ganglion cells in the retina are reactivated. Photoreceptors

in dormant sleep mode are reactivated. Nerve fibers switch

from Off mode to On mode.

Increases the electrical mobility of active drug

molecules. Increases target tissue concentrations of

drugs administered intravitreally or subtenonally.

Especially in treatment-resistant cases, the

effectiveness increases significantly after drug

applications.

How MagnoVision™ Works

neuromodulation
iontophoresis

Neuromodulation effect:

Iontophoresis effect:

1

2

2000 mGauss electromagnetic field, 42 hertz frequency

for 30 minutes from 9 different coils repetitively stimulates

the retina, optic nerve and visual pathways. Neuronal ion

channels are externally stimulated and photoreceptors and

ganglion cells in the retina are reactivated. Photoreceptors

in dormant sleep mode are reactivated. Nerve fibers switch

from Off mode to On mode.

Increases the electrical mobility of active drug

molecules. Increases target tissue concentrations of

drugs administered intravitreally or subtenonally.

Especially in treatment-resistant cases, the

effectiveness increases significantly after drug

applications.

BY INCREASING THE EFFICACY OF THE GROWTH FACTOR OR STEM CELL THERAPY,

MagnoVision MG10 MAY SLOW OR STOP THE PROGRESSION OF THE RETINITIS PIGMENTOSA,

DEEP RETINAL CAPILLARY ISCHEMIA AND CHRONIC CSCR

By simultaneously stimulating the retina, optic nerve and visual pathways
electromagnetically, it is efficient in the treatment of dystrophic,
neurodegenerative, ischemic and traumatic retinal and optic nerve diseases like

• Retinitis Pigmentosa
• Retinal Ischemic Diseases
• Chronic Central Cerous Chorioretinopathy
• Optic ToxicNeuropathies
MagboVision™

MagnoVision MG10™ can also be used in combination with

other contemporary methods when the current treatment

methods are insufficient.

MagboVision™
MagboVision™

WORLDWIDE THERE ARE APPROXIMATELY

• 50 MILLION

• 2 MILLION

DIABETIC RETINOPATHY

RETINITIS PIGMENTOSA

patients where these progressive eye diseases can result in blindness.

While these progressive neurodegenerative diseases can be treated at

varying degrees with contemporary treatment methods, in some stages

and cases they may be insufficient. MagnoVision™ MG10 therapy device,

used alone or in combination with other treatment methods, can slow or

stop blindness in appropriate cases.


Since the diseases mentioned above

usually require a long-term treatment, the patient can also use

the MagnoVision™ MG10 therapy device at home after the

treatment parameters in the control unit are set and secured by the

physician. The patient or the irrelatives should contact the physician

and / or technical service at recommended intervals or in case of need.

It is the only MDR-certified
neuroophthalmologic
electromagnetic

stimulation device in the world.

Scan the QR code to see CE certificate

Scan the QR code to see CE certificate

Innovative solutions for ophthalmology.

Committed to improving vision and

empowering eye care professionals.

Contact


info@bioretina.com.tr

+90 (312) 235 85 10

+90 (530) 321 75 90

Erler Mah. Dumlupınar Bulvarı Üstün
Dekocity İş Merkezi No:348/68
Etimesgut/ANKARA/TÜRKİYE